Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Aker BioMarine ASA's Enterprise Value is kr10,592 Mil.
Aker BioMarine ASA's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr39 Mil. Therefore, Aker BioMarine ASA's EV-to-EBIT ratio for today is 272.41.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Aker BioMarine ASA's Enterprise Value is kr10,592 Mil.
Aker BioMarine ASA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was kr621 Mil. Therefore, Aker BioMarine ASA's EV-to-EBITDA ratio for today is 17.04.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Aker BioMarine ASA's Enterprise Value is kr10,592 Mil.
Aker BioMarine ASA's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr3,677 Mil. Therefore, Aker BioMarine ASA's EV-to-Revenue ratio for today is 2.88.
Aker BioMarine ASA Enterprise Value Historical Data
The historical data trend for Aker BioMarine ASA's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Aker BioMarine ASA's Enterprise Value
For the Packaged Foods subindustry, Aker BioMarine ASA's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aker BioMarine ASA's Enterprise Value Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Aker BioMarine ASA's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Aker BioMarine ASA's Enterprise Value falls into.
Aker BioMarine ASA Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Aker BioMarine ASA's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aker BioMarine ASA (OSL:AKBM) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Aker BioMarine ASA's current Enterprise Value is kr10,592 Mil.
Aker BioMarine ASA's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr39 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Aker BioMarine ASA's current Enterprise Value is kr10,592 Mil.
Aker BioMarine ASA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr621 Mil.
Aker BioMarine ASA's current Enterprise Value is kr10,592 Mil.
Aker BioMarine ASA's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr3,677 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aker BioMarine ASA Enterprise Value Related Terms
Thank you for viewing the detailed overview of Aker BioMarine ASA's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Aker BioMarine ASA (OSL:AKBM) Business Description
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution worldwide from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include 1) The Ingredients segment involves offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products. 2) The Brands segment focuses on human consumer goods, with Lang Pharma Nutrition (Lang) and Epion as its two main components. Lang produces and distributes private-label vitamins and supplements to retailers in the U.S. market and Epion is Aker BioMarine's consumer brand company.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSL:AKBM has been successfully added to your 